Bloomberg Businessweek
Teva CEO on Staying Competitive in Generic Drug Market
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:15:50
- Mas informaciones
Informações:
Sinopsis
Kåre Schultz, CEO at Teva Pharmaceutical, talks about the company's restructuring plans as well as his outlook for drug development. He says more than 90% of U.S. pharmaceuticals are generics and one out of ten drugs is produced by Teva. Host: Jason Kelly. Producer: Doni Holloway.
